Back Stocks profile

Stock analysis tool for investors

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE:524715

₹1524.05 3.95 (0.26%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

1508.20

Today’s High

1534.90

52W low

1028.80

52W High

1638.80

Open Price

1514.00

Prev. Close

1472.7000

Volume

1370020.00

Value

2087978981.00

Fundamentals

Market Cap Cr

365670.70

Price to Earnings

38.20

Price to Book Value

5.40

Dividend Yield

0.80

PE to Growth

2.90

Op Revenue TTM Cr

48496.85

Net Profit TTM Cr

9576.38

Cash From Operating Activity Cr

12134.98

Return on Equity %

15.04

EMA & SMA

Bullish Moving Averages

15

Bearish Moving Averages

1

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

02 Jul, 2024

63

Week

60.9

Month

58

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

1522.40

PIVOT

First Resistance

1536.55

Second Resistance

1549.05

Third Resistance

1563.20

First Support

1509.90

Second Support

1495.75

Third Support

1483.25

Relative Strength Index

55.98

Money Flow Index

61.55

MACD

4.39

MACD Signal

0.04

Average True Range

29.66

Average Directional Index

20.04

Rate of Change (21)

4.4

Rate of Change (125)

21.01

Commodity Channel Index

82.9

Williams %R

-19.1

BETA

1 Month

0.41

3 Month

0.48

1 Year

0.4

3 Year

0.12

PRICE CHANGE ANALYSIS

1.98%

1 Week

Low

High

1492.3

1538.95

4.4%

1 Month

Low

High

1377.2

1538.95

-6.46%

3 Months

Low

High

1377.2

1638.85

20.93%

6 Months

Low

High

1257.15

1638.85

44.93%

1 Year

Low

High

1028.75

1638.85

Bigul
25 Jun 2024

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Closure of Trading Window

Intimation regarding closure of trading window.
24 Jun 2024

Sun Pharma Finalises Acquisition Of Taro For $347.73 Million

Taro has become a privately held company and is now a wholly owned subsidiary of Sun Pharma.
Bigul
24 Jun 2024

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Intimation regarding completion of acquisition of all outstanding shares of TARO
24 Jun 2024

Outperformance of private sector banks may continue for next one year: Sandip Sabharwal

The smaller pharma companies I find it tough to evaluate, so many of them can potentially do well but I do not have the bandwidth to go molecule by molecule and evaluate those companies. But I think Sun Pharma is a decent business model, so we are just holding it for the long term.
22 Jun 2024

Sun Pharma's investigational weight loss drug shows promise in reducing obesity

The study enrolled 24 obese male participants who were divided into two groups: one with a fixed dosage and the other with increasing dosages of GL0034. The drug not only led to significant weight loss but also enhanced insulin sensitivity and reduced glucose levels.
Bigul
22 Jun 2024

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Sun Pharma''s GL0034 demonstrates a significant Phase 1 result in an oral presentation at ADA 84th scientific sessions.
See all News

FAQs

The latest market price of Sun Pharmaceutical Industries Ltd. on NSE was Rs. 1524.05 as of today.

The opening share price of Sun Pharmaceutical Industries Ltd. was Rs. 1514.00 as of today.

The 52-week high share price of Sun Pharmaceutical Industries Ltd. was Rs. 1638.80.

The 52 week low share price of Sun Pharmaceutical Industries Ltd. was Rs. 1028.80.

Sun Pharmaceutical Industries Ltd. has a market cap of Rs. 365670.70 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Sun Pharmaceutical Industries Ltd. is 2.90. Please refer to the Fundamentals section for further details.

The operating revenue for Sun Pharmaceutical Industries Ltd. in the last FY was Rs.  48496.85 crore. Please refer to the Financials section for further details.

The Net Profit for Sun Pharmaceutical Industries Ltd. in the last FY was Rs. 9576.38 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Sun Pharmaceutical Industries Ltd. was on 2024-07-12 for Rs. 5 per share. According to today’s share price, the dividend yield of Sun Pharmaceutical Industries Ltd. stands at 0.80. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Sun Pharmaceutical Industries Ltd. was as of 2013-07-29. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Sun Pharmaceutical Industries Ltd. was as of 2003-01-13. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Sun Pharmaceutical Industries Ltd..

Close

Let's Open Free Demat Account